Department of Neurodegeneration Diagnostics, Medical University of Bialystok, Bialystok, Poland.
Department of Criminal Law and Criminology, Faculty of Law, University of Bialystok, Bialystok, Poland.
Curr Alzheimer Res. 2022;19(1):16-31. doi: 10.2174/1567205018666211202143935.
Alzheimer's disease is a progressive and deadly neurodegenerative disorder and one of the most common causes of dementia globally. Current, insufficiently sensitive and specific methods of early diagnosing and monitoring this disease prompt a search for new tools. Numerous literature data have indicated that the pathogenesis of Alzheimer's disease (AD) is not limited to the neuronal compartment but involves various immunological mechanisms. Neuroinflammation has been recognized as a very important process in AD pathology. It seems to play pleiotropic roles, both neuroprotective and neurodegenerative, in the development of cognitive impairment depending on the stage of the disease. Mounting evidence demonstrates that inflammatory proteins could be considered biomarkers of disease progression. Therefore, the present review summarizes the role of some inflammatory molecules and their potential utility in detecting and monitoring dementia severity. This paper also provides a valuable insight into new mechanisms leading to the development of dementia, which might be useful in discovering possible anti-inflammatory treatment.
阿尔茨海默病是一种进行性和致命的神经退行性疾病,也是全球最常见的痴呆症病因之一。目前,早期诊断和监测这种疾病的方法不够敏感和特异,这促使人们寻找新的工具。大量文献数据表明,阿尔茨海默病(AD)的发病机制不仅限于神经元区室,还涉及各种免疫机制。神经炎症已被认为是 AD 病理学中非常重要的过程。它在认知障碍的发展中似乎发挥着多效作用,既有神经保护作用,也有神经退行性作用,具体取决于疾病的阶段。越来越多的证据表明,炎症蛋白可以被认为是疾病进展的生物标志物。因此,本综述总结了一些炎症分子的作用及其在检测和监测痴呆严重程度方面的潜在用途。本文还深入探讨了导致痴呆发生的新机制,这可能有助于发现可能的抗炎治疗方法。